COMMUNIQUÉS West-GlobeNewswire

Idorsia announces financial results for the first quarter 2018

19/04/2018 - 07:01

Allschwil, Switzerland - 19 April 2018 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first quarter of 2018. Jean-Paul Clozel, MD and Chief Executive Officer, commented : "We are advancing four [...]

Bone Therapeutics Notice of Full Year 2017 Results

19/04/2018 - 07:01

Press release Bone Therapeutics Notice of Full Year 2017 Results Results to be announced on Wednesday 25 April 2018 Gosselies, Belgium, 19 April 2018, 7am CEST - BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), [...]

Bone Therapeutics publiera ses résultats financiers 2017, le mercredi 25 avril 2018

19/04/2018 - 07:01

Communiqué de presse Bone Therapeutics publiera ses résultats financiers 2017, le mercredi 25 avril 2018 Gosselies, Belgique, le 19 avril 2018, 7h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE, [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

19/04/2018 - 07:01

REGULATED INFORMATION GHENT, Belgium, 19 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

Aeglea BioTherapeutics Prices Public Offering of Common Stock

19/04/2018 - 04:50

AUSTIN, Texas, April 18, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc., (Nasdaq: AGLE ) a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with [...]

Apellis Pharmaceuticals Announces Pricing of Offering of Common Stock

19/04/2018 - 03:26

CRESTWOOD, Ky. and WALTHAM, Mass., April 18, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS ), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds [...]

Surface Oncology Announces $119.5 Million Aggregate Financing, Consisting of $108.0 Million Initial Public Offering and $11.5 Million Concurrent Private Placement

19/04/2018 - 03:00

CAMBRIDGE, Mass., April 18, 2018 (GLOBE NEWSWIRE) -- Surface Oncology, Inc. (“Surface”) (Nasdaq: SURF ), a clinical-stage immuno-oncology company developing next-generation antibody therapies that target the tumor [...]

Health Point Productions' Gene Wilder Bio-Documentary Moving Forward

18/04/2018 - 23:25

New Film on Beloved Star’s Life & his Battle with Alzheimer's Disease LOS ANGELES, April 18, 2018 (GLOBE NEWSWIRE) -- "Gene Wilder, a prolific actor and screenwriter best known for such classic films: Young [...]

National Research Corporation to Broadcast its 2018 First Quarter Conference Call Live on the Internet

18/04/2018 - 23:00

Lincoln, Nebraska, April 18, 2018 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2018 first quarter conference call on Wednesday, May [...]

LeMaitre Vascular Will Announce First Quarter 2018 Earnings Results on April 25, 2018

18/04/2018 - 22:35

BURLINGTON, Mass., April 18, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT ) announced today that it will release its first quarter 2018 financial results on Wednesday, April 25, 2018, after the market [...]

Parliamentary report echoes nurses’ twenty-year call for universal pharmacare

18/04/2018 - 22:28

OTTAWA, April 18, 2018 (GLOBE NEWSWIRE) -- Canada’s nurses applaud today’s release of Pharmacare Now , a report by the House of Commons health committee, recommending the development of a national, universal [...]

Un rapport de la Chambre des communes fait écho aux infirmières et infirmiers qui demandent depuis vingt ans un régime universel d’assurance-médicaments

18/04/2018 - 22:28

OTTAWA, 18 avr. 2018 (GLOBE NEWSWIRE) -- Les infirmières et les infirmiers du Canada applaudissent le rapport Un régime d’assurance-médicaments universel pour tous les Canadiens : une nécessité, communiqué aujourd’hui [...]

Flexion Therapeutics Announces Publication of Results from Pivotal Phase 3 Study of ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) in the Journal of Bone and Joint Surgery

18/04/2018 - 22:20

BURLINGTON, Mass., April 18, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced that the key results from the previously completed pivotal Phase 3 study evaluating ZILRETTA ( [...]

Qu Biologics Begins Phase 2 Clinical Trial in Crohn’s Disease

18/04/2018 - 22:16

VANCOUVER, British Columbia, April 18, 2018 (GLOBE NEWSWIRE) -- Qu Biologics Inc. (Qu), a Vancouver, Canada-based biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of [...]

CohBar, Inc. Announces Voluntary Delisting from the TSX Venture Exchange

18/04/2018 - 22:05

Common stock will continue to trade on the Nasdaq Capital Market MENLO PARK, Calif., April 18, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR ) and (TSXV:COB.U) (“CohBar” or the “Company”) today announced that it [...]

Sandoz signs agreement with Pear Therapeutics to develop and commercialize prescription digital therapeutics for patients with substance use disorder and opioid use disorders

18/04/2018 - 22:02

Deal includes reSET®, cleared by FDA for treatment of patients with Substance Use Disorder, and reSET-O(TM), potential treatment pending FDA clearance for patients with Opioid Use Disorder treated with buprenorphine [...]

Pre-Clinical Data Demonstrating Promising Potential of Prexigebersen as Treatment for Solid Tumors in Gynecologic Malignancies Presented at American Association for Cancer Research Annual Meeting

18/04/2018 - 22:01

HOUSTON, April 18, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH ), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]

Krystal Biotech Presents Their Skin TARgeted Delivery Platform at the World Orphan Drug Congress USA

18/04/2018 - 22:01

PITTSBURGH, April 18, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS ), a gene therapy company developing “off-the-shelf” treatments for rare dermatological diseases, today announces a [...]

Sientra Receives FDA Approval of PMA Supplement

18/04/2018 - 22:01

Commercial Sale of U.S.-Manufactured OPUS™ Branded Breast Implants to Begin Immediately Additional $10 Million of Existing Credit Facility Now Accessible with FDA Approval SANTA BARBARA, Calif., April 18, 2018 (GLOBE [...]